SNS 공유

팝업닫기

SNS 공유

팝업닫기

논문업적

  1. HOME
  2. KCSG 연구지원
  3. 논문업적

등록된 논문 166

※ 클릭시 해당 논문페이지로 이동합니다.

  • KCSG LU23-15폐암

    Delayed central nervous system progression with atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer (LU23-15)

    • 저널 Lung Cancer. 2025 Mar:201:108455.
    • 제1저자 이경민, 김태환
    • 교신저자 강은주, 안희경
  • KCSG HN15-16두경부식도암

    Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial

    • 저널 Cancer Res Treat. 2025 Jan 31.
    • 제1저자 김규현
    • 교신저자 김성배, 홍민희, 김혜련
  • KCSG GU20-03비뇨기암

    A Multicenter Phase II Study of Modified FOLFIRINOX for First-line Treatment for Advanced Urachal Cancer (ULTMA; KCSG GU20-03)

    • 저널 Cancer Res Treat. 2025 Feb 13.
    • 제1저자 박인근
    • 교신저자 이재련
  • KCSG BR15-10유방암

    Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study

    • 저널 Lancet Oncol. 2025 Mar;26(3):343-354.
    • 제1저자 안희경, 김지연
    • 교신저자 박연희, 임석아
  • KCSG GU16-05비뇨기암

    Pemetrexed Maintenance versus Observation in Patients with Advanced Urothelial Carcinoma Who Completed First-line Platinum-based Chemotherapy without Disease Progression (PREMIER, KCSG GU16-05)

    • 저널 Cancer Res Treat . 2024 Dec 27.
    • 제1저자 박인근
    • 교신저자 이재련
  • KCSG AL20-05기타

    Nationwide precision oncology pilot study: KOrean Precision Medicine Networking Group Study of MOlecular profiling-guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) KCSG AL-20-05

    • 저널 ESMO Open. 2024 Oct;9(10):103709.
    • 제1저자 김태용
    • 교신저자 김지현
  • KCSG BR17-06유방암

    A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer

    • 저널 NPJ Breast Cancer. 2024 Aug 22;10(1):76.
    • 제1저자 Emi Noguchi
    • 교신저자 Kan Yonemori
  • KCSG HB22-21간담췌암

    Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries

    • 저널 Karger. 2024 Aug 20
    • 제1저자 이충근, 유창훈
    • 교신저자 전홍재, 이명아
  • KCSG PC20-12완화의료

    Efficacy of transdermal buprenorphine patch for managing withdrawal symptoms in patients with cancer physically dependent on prescription opioids

    • 저널 Oncologist . 2024 Nov 4;29(11):e1593-e1603.
    • 제1저자 강정훈, 이경희, 허석재
    • 교신저자 고세일
  • KCSG LU22-18폐암

    Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18

    • 저널 JTO Clin Res Rep . 2024 Oct 16;5(12):100734.
    • 제1저자 최대호, 김미소
    • 교신저자 안명주

맨앞으로앞으로12345뒤로맨뒤로

뒤로
뒤로

홈

임상연구
임상연구

교육
교육